Jaguar Health, Inc. (NASDAQ:JAGX) shares are trading lower Thursday, and the stock is down more than 65% over the past five days.
The Details:
Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order to support the company's compliance with Nasdaq listing requirements.
Last week, Jaguar reported worse-than-expected first-quarter results with losses of 6 cents per share, compared to the losses of 3 cents per share analyst estimate. Quarterly sales also came in below the consensus estimate at $2.351 million.
Jaguar Health is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid and ...